Your CDMO
Pharmaceutical Partner

Discovery

Sterling’s comprehensive analytical and medicinal chemistry expertise, and strong focus on scientific collaboration, enables success in the discovery phase with an eye on containing costs, adhering to deadlines and impact on future phases in the lifecycle.

Preclinical

We pair process development services, including proof of concept, quality by design, and design of experiments, with CMC support for the IND process to establish an efficient, cost-effective, and scalable pathway to market.

Phase One

As our customers prepare for phase I clinical trials, we help them select an appropriate regulatory starting material (RSM), manufacture an appropriate amount of product for clinical trials and generate the necessary regulatory data to enhance their chance of success.

Phase Two

After a product moves through phase I, we continue to accelerate the development of materials for clinical trials and generate critical regulatory data, with process optimisation being a key focus for our scientific and engineering teams.

Phase Three

In this critical phase, we finalise data and process validation, and prepare for commercial manufacture. Scale, efficiency, quality control, integrity, and compliance are all top priorities as we navigate the last phase prior to commercial launch.

Launch

At this stage process optimisation is key to enhance efficiency and save costs, whilst ensuring the quality of the product and adherence to regulatory controls in terms of process change.